Showing 61 to 72 of 214 results


WeightWatchers Partners with GLP-1 Provider Amidst Financial Troubles
WeightWatchers, facing bankruptcy in the US, partners with UK GLP-1 weight-loss medication provider CheqUp, integrating its app to support users of weight-loss injections like Wegovy and Mounjaro, aiming for improved and sustainable weight loss, as demand for traditional programs declines.
WeightWatchers Partners with GLP-1 Provider Amidst Financial Troubles
WeightWatchers, facing bankruptcy in the US, partners with UK GLP-1 weight-loss medication provider CheqUp, integrating its app to support users of weight-loss injections like Wegovy and Mounjaro, aiming for improved and sustainable weight loss, as demand for traditional programs declines.
Progress
48% Bias Score


West Midlands Towns Report Highest Obesity Rates in UK
Three West Midlands towns—Walsall, Cannock Chase, and Tamworth—have the UK's highest obesity rates, with 36.2%, 37.8%, and 37.4% of residents, respectively, attributed to the cost of healthy food and easy access to fast food.
West Midlands Towns Report Highest Obesity Rates in UK
Three West Midlands towns—Walsall, Cannock Chase, and Tamworth—have the UK's highest obesity rates, with 36.2%, 37.8%, and 37.4% of residents, respectively, attributed to the cost of healthy food and easy access to fast food.
Progress
52% Bias Score


Excessive Sugar Consumption: Historical Roots, Health Impacts, and Potential Solutions
The widespread consumption of sugar, originating from Arab introduction in the 7th and 8th centuries, now contributes to significant health problems like obesity and diabetes in many countries, leading to various interventions such as sugar taxes and behavioral therapies.
Excessive Sugar Consumption: Historical Roots, Health Impacts, and Potential Solutions
The widespread consumption of sugar, originating from Arab introduction in the 7th and 8th centuries, now contributes to significant health problems like obesity and diabetes in many countries, leading to various interventions such as sugar taxes and behavioral therapies.
Progress
44% Bias Score


Weight-Loss Injections Show Promise in Extending Lifespans, Preventing Diseases
New weight-loss injections, GLP-1 agonists like Mounjaro and Wegovy, show promise in delaying age-related illnesses and reducing heart attack risk by half, based on a 17,000-patient trial, leading experts to suggest expanded access for up to half of Britons to improve health and longevity.
Weight-Loss Injections Show Promise in Extending Lifespans, Preventing Diseases
New weight-loss injections, GLP-1 agonists like Mounjaro and Wegovy, show promise in delaying age-related illnesses and reducing heart attack risk by half, based on a 17,000-patient trial, leading experts to suggest expanded access for up to half of Britons to improve health and longevity.
Progress
52% Bias Score


Weight-Loss Injections May Almost Halve Obesity-Related Cancer Risk
A study of 6,000 adults found that weight-loss injections, specifically GLP-1RAs, may reduce the risk of obesity-related cancers by almost 50%, a finding comparable to bariatric surgery; this discovery could lead to a new era of preventive cancer medicine.
Weight-Loss Injections May Almost Halve Obesity-Related Cancer Risk
A study of 6,000 adults found that weight-loss injections, specifically GLP-1RAs, may reduce the risk of obesity-related cancers by almost 50%, a finding comparable to bariatric surgery; this discovery could lead to a new era of preventive cancer medicine.
Progress
48% Bias Score


Diabetes Epidemic Devastates McAllen Family, Exposing City's Health Crisis
In McAllen, Texas, known as "America's fattest city," the Ceron family's tragic history with diabetes—three siblings died from the disease, others experienced amputations and blindness—exposes the city's alarmingly high diabetes rate (19.2% in Hidalgo County vs. 11.6% nationally), highlighting the u...
Diabetes Epidemic Devastates McAllen Family, Exposing City's Health Crisis
In McAllen, Texas, known as "America's fattest city," the Ceron family's tragic history with diabetes—three siblings died from the disease, others experienced amputations and blindness—exposes the city's alarmingly high diabetes rate (19.2% in Hidalgo County vs. 11.6% nationally), highlighting the u...
Progress
48% Bias Score

UK Heart Health Declines Sharply: Deaths and Diagnoses Soar
The UK is experiencing the worst start to a decade for heart health in 50 years, with cardiovascular deaths among working-age adults rising by 18% since 2019 to 21,975 in 2023, alongside record increases in heart failure, atrial fibrillation, and diabetes diagnoses, and lengthening hospital waiting ...

UK Heart Health Declines Sharply: Deaths and Diagnoses Soar
The UK is experiencing the worst start to a decade for heart health in 50 years, with cardiovascular deaths among working-age adults rising by 18% since 2019 to 21,975 in 2023, alongside record increases in heart failure, atrial fibrillation, and diabetes diagnoses, and lengthening hospital waiting ...
Progress
32% Bias Score

Fast Eating Linked to Digestive Problems, Type 2 Diabetes, and Weight Gain
Research indicates a link between fast eating and various health issues, including digestive problems, type 2 diabetes, and weight gain; studies suggest slowing down eating pace as a preventative measure.

Fast Eating Linked to Digestive Problems, Type 2 Diabetes, and Weight Gain
Research indicates a link between fast eating and various health issues, including digestive problems, type 2 diabetes, and weight gain; studies suggest slowing down eating pace as a preventative measure.
Progress
44% Bias Score

GLP-1 Receptor Agonists Show Comparable Effectiveness to Bariatric Surgery in Reducing Obesity-Related Cancer Risk
An Israeli study of 6,356 obese individuals with diabetes found that GLP-1 receptor agonists (GLP-1 RAs) and bariatric metabolic surgery showed similar low rates of obesity-related cancers, with GLP-1 RAs showing a 41% relative risk reduction compared to surgery; further research is needed to confir...

GLP-1 Receptor Agonists Show Comparable Effectiveness to Bariatric Surgery in Reducing Obesity-Related Cancer Risk
An Israeli study of 6,356 obese individuals with diabetes found that GLP-1 receptor agonists (GLP-1 RAs) and bariatric metabolic surgery showed similar low rates of obesity-related cancers, with GLP-1 RAs showing a 41% relative risk reduction compared to surgery; further research is needed to confir...
Progress
40% Bias Score

GLP-1 Weight-Loss Drugs May Reduce Obesity-Related Cancer Risk by 41%
A study of nearly 6,400 obese and diabetic individuals found that GLP-1 receptor agonists, while less effective for weight loss than bariatric surgery, may reduce obesity-related cancer risk by 41%, potentially through inflammation reduction; however, this observational study requires further invest...

GLP-1 Weight-Loss Drugs May Reduce Obesity-Related Cancer Risk by 41%
A study of nearly 6,400 obese and diabetic individuals found that GLP-1 receptor agonists, while less effective for weight loss than bariatric surgery, may reduce obesity-related cancer risk by 41%, potentially through inflammation reduction; however, this observational study requires further invest...
Progress
20% Bias Score

Weight Loss Injections' Rise Contributes to Weight Watchers' Bankruptcy
Simon, 34, lost 26 kg using Monjaro weight loss injections after years of failed dieting, including with Weight Watchers which has lost over a million members and filed for bankruptcy amid the rise of weight loss injections and social media.

Weight Loss Injections' Rise Contributes to Weight Watchers' Bankruptcy
Simon, 34, lost 26 kg using Monjaro weight loss injections after years of failed dieting, including with Weight Watchers which has lost over a million members and filed for bankruptcy amid the rise of weight loss injections and social media.
Progress
56% Bias Score

Weight Loss Injections Could Boost UK Economy by £4.5 Billion
Research presented at the European Congress on Obesity in Málaga estimates that providing semaglutide to eligible UK residents could boost the economy by £4.5 billion due to increased productivity among 2,660 trial participants who gained an average of 17 extra workdays annually, offsetting some of ...

Weight Loss Injections Could Boost UK Economy by £4.5 Billion
Research presented at the European Congress on Obesity in Málaga estimates that providing semaglutide to eligible UK residents could boost the economy by £4.5 billion due to increased productivity among 2,660 trial participants who gained an average of 17 extra workdays annually, offsetting some of ...
Progress
44% Bias Score
Showing 61 to 72 of 214 results